CM.TO 1.58V 5.38NRIM 0CSU.TO 12.96NA.TO 2.87META -0.8EXPE 5.16CIGI.TO 3.74
Aptose Biosciences (APS.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

TSE:APS

Aptose Biosciences (APS.TO)

2.33
+0.13 (5.91%)
as of Jun 9, 2026, 7:56:30 pm Market Open.
10 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Aptose Biosciences(APS.TO)

May 10, 2001
Expects good results by year end on their product. A fan.
Photo of Malvin SpoonerMalvin SpoonerUnlock Rating
$1.80

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

May 04, 2001
Smaller company and only one product.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$1.65

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

May 01, 2001
Good strategy. In the early stages, so is risky. Very small company.
Photo of Ray SteeleRay SteeleUnlock Rating
$1.62

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Mar 15, 2001
Interesting company. Well capitalized. A lot of cancer solutions.
Photo of Robert FloydRobert FloydUnlock Rating
$1.72

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Aptose Biosciences(APS.TO)

Mar 14, 2001
Usually BURNS money rather than earning any.
Photo of Malvin SpoonerMalvin SpoonerUnlock Rating
$1.70

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
WAIT

Aptose Biosciences(APS.TO)

Feb 21, 2001
High risk/high return. Early days yet. Only one drug.
Photo of Phil SmithPhil SmithUnlock Rating
$2.13

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Feb 19, 2001
Likes. Good balance sheet and cash position. News is good and like their sector.
Photo of Robert FloydRobert FloydUnlock Rating
$2.59

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Feb 14, 2001
Getting hit because of nervous market. Risky
Photo of Ray SteeleRay SteeleUnlock Rating
$2.00

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Feb 01, 2001
Attractive at current valuations. Has some promise
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$2.44

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY ON WEAKNESS

Aptose Biosciences(APS.TO)

Jan 23, 2001
A trading stock as compared to a holding stock. Volatile
Photo of Steven MisenerSteven MisenerUnlock Rating
$1.84

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
STRONG BUY

Aptose Biosciences(APS.TO)

Jan 19, 2001
Likes good prospects. Undervalued. RISK/Reward over next few months = REWARD
Photo of Pier DonniniPier DonniniUnlock Rating
$1.86

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Jan 12, 2001
Speculative. Have to know/understand them well
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$1.82

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
WAIT

Aptose Biosciences(APS.TO)

Dec 29, 2000
Good company, but still developing their drug
Photo of Fred KetchenFred KetchenUnlock Rating
$1.83

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Oct 13, 2000
OK, but diversify. Good platform. To move, it needs news to drive
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$2.00

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
Showing 31 to 44 of 44 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

RPRX 0.77$55.63
URA -1.8$44.12
BBD.B.TO 3.33$305.83
X.TO 0.55$50.44
TRI.TO -1.25$114.87

Today's Top Picks

CM.TO 1.58$154.53
V 5.38$325.05
NRIM 0$
CSU.TO 12.96$2975.35
NA.TO 2.87$207.27

Popular Articles

Latest Sell Signals

MDA.TO -1.44$52.57
CPRT 0.45$31.31
TEVA 1.19$34.45
GLXY.TO -1.39$28.26
XNDU.TO 0.55$50.44

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica